1 Recommendation

Integration and harmonization opportunities in Hep C

By Francesco Marinucci | 28 Jul, 2017

As we mark World Hepatitis Day today, it is important to note that the availability of oral direct acting antiviral (DAA) regimens has created momentum around the elimination of Hepatitis C. Several countries have started to take concrete steps by establishing national viral hepatitis strategies and rolling out implementation plans. Elimination of Hepatitis C seems to be at an arm’s length, but major barriers still remain for an effective and durable public health intervention.

The shortage of international funding streams for hepatitis C might be seen as a barrier but it can also represent a unique opportunity to explore innovative approaches for integration. The information note recently issued by WHO highlighting some key considerations for collaboration and integration is a first step in this direction. In the near future it will be interesting to support these changes that will certainly stimulate groundbreaking ways to create sustainable synergies and effective harmonization across disease-specific programs. Are there any positive/negative lessons learned from the HIV and TB integration that we should take into account? Can the private sector play any catalytic effect to facilitate this integration?



This Community is Archived.

This community is no longer active as of December 2018. Thanks to those who posted here and made this information available to others visiting the site.